
Experimental Cancer Therapy Makes Inroads Treating Brain Cancer
The immunotherapy approach may soon be commercially available for leukemia and lymphoma
The immunotherapy approach may soon be commercially available for leukemia and lymphoma
Celebrity deaths highlight challenges still facing medicine
"It never occurred to me that he was the oldest president"
One clinic's youngest patient is 3
The findings raise questions about if those physicians' methods could be pinpointed and copied
The agency will require new warnings on medication labels
The president-elect's pick for HHS head supports such a change
Jim O'Neill is not a physician, but he speaks frequently at biotech industry meetings
Phage therapy is not approved for regular use by the FDA
The hearing offers each side 20 minutes to make its case
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account